Suppr超能文献

中国深圳9至50岁女性首剂人乳头瘤病毒疫苗接种率:基于2023年行政健康记录的监测

Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9-50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023.

作者信息

Lin Zian, Liang Xue, Su Lixian, Peng Weijun, Chen Hongbiao, Fang Yuan, Chen Siyu, Yang Weikang, Chen Wensheng, Zhang Lijun, Wang Zixin

机构信息

Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, China.

Centre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.

出版信息

Vaccines (Basel). 2024 Jan 12;12(1):75. doi: 10.3390/vaccines12010075.

Abstract

China started to offer human papillomavirus (HPV) vaccines to females aged 9-45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors among females aged 9-50 years in Shenzhen, China, based on administrative health records kept by community health centers. A multistage random sampling approach was used. The research team randomly selected 18 community health centers in Shenzhen, and 3118 health records of females aged 9-50 years were then randomly selected from these health centers. Among all participants, 18.7% received at least one dose of HPV vaccination. The highest coverage was observed among females aged 18-26 years (23.4%), followed by those aged 27-35 years (22.0%) and 36-45 years (20.2%). Such coverage was very low among females aged 9-17 years (4.6%) and those aged 46-50 years (3.2%). Among females aged 18 years or above, higher education level, having a family doctor, and permanent residency in Shenzhen were associated with higher HPV vaccination coverage, while older age and being married/divorced were negatively associated with coverage. The HPV vaccination coverage in Shenzhen was 18.7% and there is a strong need for improvement.

摘要

中国于2016年开始为9至45岁的女性提供人乳头瘤病毒(HPV)疫苗。然而,在中国,缺乏关于具有代表性的女性样本中HPV疫苗接种覆盖率的报告。因此,本研究旨在基于社区卫生中心保存的行政健康记录,调查中国深圳9至50岁女性目前的HPV疫苗接种覆盖率及相关因素。采用了多阶段随机抽样方法。研究团队随机选取了深圳的18家社区卫生中心,然后从这些卫生中心随机抽取了3118份9至50岁女性的健康记录。在所有参与者中,18.7%的人接种了至少一剂HPV疫苗。18至26岁的女性接种覆盖率最高(23.4%),其次是27至35岁的女性(22.0%)和36至45岁的女性(20.2%)。9至17岁的女性(4.6%)和46至50岁的女性(3.2%)的接种覆盖率非常低。在18岁及以上的女性中,较高的教育水平、拥有家庭医生以及在深圳拥有永久居留权与较高的HPV疫苗接种覆盖率相关,而年龄较大以及已婚/离异则与接种覆盖率呈负相关。深圳的HPV疫苗接种覆盖率为18.7%,有很大的提升需求。

相似文献

2
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.
3

本文引用的文献

1
Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.
Infect Dis Poverty. 2023 Sep 21;12(1):86. doi: 10.1186/s40249-023-01136-6.
3
HPV Vaccination Adherence in Working-Age Men: A Systematic Review and Meta-Analysis.
Vaccines (Basel). 2023 Feb 15;11(2):443. doi: 10.3390/vaccines11020443.
4
5
Willingness of parents of 9-to-18-year-old females in China to vaccinate their daughters with HPV vaccine.
Vaccine. 2023 Jan 4;41(1):130-135. doi: 10.1016/j.vaccine.2022.11.016. Epub 2022 Nov 18.
6
Discrepancy of human papillomavirus vaccine uptake and intent between girls 9-14 and their mothers in a pilot region of Shanghai, China.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2132801. doi: 10.1080/21645515.2022.2132801. Epub 2022 Oct 28.
7
Stages of HPV Vaccine Hesitancy Among Guardians of Female Secondary School Students in China.
J Adolesc Health. 2023 Jan;72(1):73-79. doi: 10.1016/j.jadohealth.2022.08.027. Epub 2022 Oct 11.
9
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
10
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.
Vaccines (Basel). 2021 Nov 30;9(12):1413. doi: 10.3390/vaccines9121413.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验